Improving survival of 3760 patients with lymphoma: Experience of an academic center over two decades

Key Points

Assess long-term trends in survival outcomes across various lymphoma subtypes over a 20-year period.
Retrospective cohort study analyzing N=3760 patients with lymphoma treated at a single academic center over two decades.
Evaluated survival trends across major disease subtypes, including classical Hodgkin lymphoma (cHL), mature B-cell lymphoma (BCL), and peripheral T-cell lymphoma (PTCL).
Survival significantly improved over the two-decade observation period for patients with classical Hodgkin lymphoma and mature B-cell lymphoma.

Cohort study reveals significant survival improvements in patients with lymphoma, highlighting lagging progress in peripheral T-cell subtypes.

The survival of most types of lymphoma such as cHL and mature BCL, rather than PTCL, was improved significantly during the past two decades.

No takes yet. Share an insight, caveat, or question.

Liu et al. (2020) studied this question.

View Full Paper

Ask AI

Bookmark

Share